Annual report pursuant to Section 13 and 15(d)

Leases

v3.8.0.1
Leases
12 Months Ended
Dec. 31, 2017
Leases [Abstract]  
Leases
Leases
Operating leases
We conduct certain of our operations under operating lease agreements. Rent expense under operating leases was approximately $18.9 million, $18.8 million, and $7.8 million for the years ended December 31, 2017, 2016, and 2015, respectively.
As of December 31, 2017, the aggregate future minimum lease payments under all non-cancelable operating leases with initial or remaining lease terms in excess of one year are as follows: 
Year Ending
(In thousands)
2018
$
19,059

2019
15,166

2020
9,360

2021
6,079

2022
3,148

Thereafter
3,542

Total minimum operating lease commitments
$
56,354


Capital leases
We acquired various assets under capital leases in connection with our acquisition of BioReference in 2015. Capital leases are included within Property, plant and equipment, net in our Consolidated Balance Sheet with imputed interest rates of approximately 2% as follows:
Capital leases
Year ended December 31, 2017
Automobiles
$
11,137

Less: Accumulated Depreciation
(4,366
)
Net capital leases in Property, plant and equipment
$
6,771


As of December 31, 2017, the aggregate future minimum lease payments under all non-cancelable capital leases with initial or remaining lease terms in excess of one year are as follows: 
Year Ending
(In thousands)
2018
$
3,521

2019
3,029

2020
2,440

2021
1,586

2022
410

Thereafter
441

Total minimum capital lease commitments
11,427

Less: Amounts representing interest
242

Net capital liability
$
11,185

 
 
Current
$
3,399

Long-term
$
7,786